Skip to main content
. 2017 Feb 13;32(4):700–703. doi: 10.3346/jkms.2017.32.4.700

Table 1. Clinical characteristics, causes of death, and DST results of patients with early and late death during ATT.

Variables Early death (n = 36) Late death (n = 38) P value
Age, yr 78 (71–85) 76 (71–83) 0.327
Age > 70 yr, No. (%) 28 (78) 30 (79) 0.903
Male, No. (%) 26 (72) 25 (66) 0.550
Low BMI (< 18.5 kg/m2), No. (%) 12 (33) 9 (24) 0.357
Prior TB history, No. (%) 3 (8) 5 (13) 0.712
Comorbidities, No. (%)
 None 12 (33) 10 (26) 0.509
 Diabetes mellitus 10 (28) 8 (21) 0.500
 Chronic heart disease 5 (14) 6 (16) 0.818
 Chronic lung disease 5 (14) 1 (3) 0.103
 Chronic liver disease 5 (11) 1 (3) 0.103
 Chronic kidney disease 2 (6) 5 (13) 0.431
 Neurologic disease 3 (8) 1 (3) 0.351
 Malignancy 4 (11) 15 (40) 0.005
Anemia (male < 13 g/dL, female < 12 g/dL), No. (%) 28 (78) 29 (76) 0.881
Site of TB, No. (%) 0.602
 Pulmonary alone 29 (81) 31 (82)
 Pulmonary + extrapulmonary 6 (17) 4 (11)
 Extrapulmonary alone 1 (3) 3 (8)
Severe degree of pul-TB on chest X-ray, No. (%) 19 (53) 12 (32) 0.065
Smear-positive sputum, No. (%) 19/34 (56) 20/32 (63) 0.585
Time from presentation to hospital to ATT, day 1 (1–3) 5 (1–14) < 0.001
Time from ATT to death, day 21 (7–38) 131 (99–226) < 0.001
DST to first-line drugs, No. (%) 0.707
 All sensitive 30 (83) 32/37 (86) -
 Any resistance 6 (17) 5/37 (14) 1.000
  Isoniazid resistance 4 (11) 5/37 (14) 0.240
  Multi-drugs resistance 2 (6) 0/37 (0) -
Cause of death < 0.001
 TB-related 20 (56) 4 (11)
 TB-unrelated 16 (44) 34 (89)

BMI = body mass index, TB = tuberculosis, pul-TB = pulmonary tuberculosis, ATT = anti-tuberculosis treatment, DST = drug susceptibility test, IQR = interquartile range.